HCV Post-Exposure Prophylaxis for Health Care Workers

Withdrawn before enrolling · Phase 4

Conditions studied: Hepatitis C

In brief

This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.

Key facts

Study ID

NCT03313414

Run by

Massachusetts General Hospital

People needed

0

Starts

2019-08-13

Expected to finish

2020-01-16

Last updated by the study team

2020-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Healthcare worker with exposure through needlestick injury with hollow-bore needles to source patients who are HCV positive
• Healthcare worker must be HCV Ab-

You may not qualify if…

• HCV Ab positive
• HCV Ab negative and HCV RNA greater than 1000 IU/ml
• Active malignancy
• Positive urine pregnancy test

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.